Novel targeting of therapy-resistant prostate cancer cells. [ 2018 - 2020 ]

Research Grant

Researchers: Dr Renea Taylor (Principal investigator) ,  A/Pr Arun Azad ,  Prof Gail Risbridger

Brief description Prostate cancer is treated by removing male hormones (androgens). Although the bulk of the tumour regresses, some cells remain and the cancer often grows back in an aggressive form. We will study new ways to eliminate therapy resistant cancer cells and thereby provide more lasting treatments for prostate cancer. Ultimately, we hope to inform the design of ground-breaking clinical trials that could re-shape the treatment paradigm of advanced prostate cancer.

Funding Amount $AUD 605,335.69

Funding Scheme Project Grants

Notes Standard Project Grant